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Maternal mortality among women with coronavirus
disease 2019 admitted to the intensive care unit
OBJECTIVE:
Limited data are available on critically ill pregnant women hospitalized with coronavirus disease 2019
(COVID-19). Although maternal mortality has been
reported,1e3 the frequency with which this devastating
outcome occurs is unknown. The objective of this study was
to determine the rate of maternal death among pregnant and
postpartum women with COVID-19 admitted to the
intensive care units (ICUs) in a large integrated health
system in the New York metropolitan area. In this study, we
described patient demographics, baseline comorbidities,
clinical presentation, hospital course, and maternal outcomes.

This case series evaluated all consecutively
hospitalized pregnant and immediately postpartum women
with laboratory-conﬁrmed diagnosis of COVID-19 who were
admitted to the ICUs at 10 hospitals within Northwell
Health, the largest academic health system in New York, and
Maimonides Medical Center, an afﬁliate of Northwell Health
in Brooklyn, NY, from March 1, 2020, to May 6, 2020.
Collectively, these hospitals perform approximately 40,000
deliveries per year, representing about 1 in 6 births in the
state of New York and 1% of all births in the United States.
Respiratory specimens were collected using nasopharyngeal
swabs. Symptomatic patients who received positive test
results for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) by polymerase chain reaction (PCR) assay
were included. Admission to the ICU was at the discretion
of the consulted critical care attending physician at each site.
Patients who had a critical care consultation but were not
directly managed by an intensivist were not included.
Women who received positive test results for the virus but
were admitted to the ICU for indications other than acute or
impending hypoxemic respiratory failure were excluded (eg,
postpartum hemorrhage). The Northwell Health Institutional
Review Board approved this case series as minimal-risk
research that used data collected for routine clinical practice
and waived the requirement for informed consent. Some
women in this study were included in previous publications
characterizing COVID-19 hospitalizations within the
Northwell Health system,4,5 whereas 1 maternal death was
previously presented as a case report.1
Clinical data were obtained from the electronic health record system. Subject records were reviewed manually. Data
collected included demographics, medical comorbidities,
duration of illness before hospitalization, laboratory and
imaging results, ICU treatments, and clinical outcomes. No
patients were postpartum at the time of hospital admission.
The primary outcome was maternal death. Secondary outcomes included length of hospitalization and ICU stay, frequency and duration of invasive mechanical ventilation (ie,
STUDY DESIGN:

requiring endotracheal intubation), frequency of vasopressor
administration, urgent or emergent delivery associated with
acute respiratory decompensation, and discharge from the
hospital. Descriptive statistics were used to characterize the
data. Results are presented as means and standard deviations
or medians and interquartile ranges, as appropriate. Categorical variables were expressed as numbers and percentages.
Between March 1, 2020, and May 6, 2020, at the
11 included hospitals, there were 462 pregnant women who
received positive test results for SARS-CoV-2, and 70 (15%)
patients were classiﬁed as having severe or critical COVID19 per National Institutes of Health (NIH) criteria. Out of
these 70 patients, a total of 13 (19%) were admitted to the
ICUs for acute or impending hypoxemic respiratory failure
(Figure). Among this group, 2 (15%) died, and 11 (85%)
were discharged from the hospital.
Women admitted to the ICUs had a mean maternal age of
33.85.2 years, and 69% were multiparous (Supplemental
Table 1). Hispanic women constituted the largest racial or
ethnic group (38%). The most common comorbidities were
obesity (38%) and pulmonary conditions (23%) such as
asthma and obstructive sleep apnea (OSA). However, nearly
half of the patients (46%) had no baseline comorbidities. All
pregnancies were singleton gestations. Most patients were
tachycardic, tachypneic, and hypoxemic on initial evaluation,
and few were febrile. Nearly all patients (92%) met the NIH
criteria for severe COVID-19 at admission. Lymphopenia,
elevated transaminases, and elevated inﬂammatory markers
were common laboratory ﬁndings (Supplemental Table 2).
The mean gestational age of pregnant women with COVID19 at hospitalization was 33.35.3 weeks, and symptoms
started 83 days before admission.
The median length of hospitalization and ICU stay were 13
and 8 days, respectively (Supplemental Table 3). The duration
of hospitalization before ICU admission and after ICU
discharge were 22 and 33 days, respectively. Invasive
mechanical ventilation was required in 8 (62%) cases (at
initiation, 6 were postpartum and 2 were pregnant), and the
median duration of therapy was 8 days. Among this group, 7
(88%) required vasopressors. One patient was extubated but
remained ventilator dependent with a tracheostomy. All patients admitted to the ICUs received either prophylactic or
therapeutic dose anticoagulation (100%); there were no
known cases of venous thromboembolism. Most patients
were administered hydroxychloroquine (85%) and antibiotics
for community-acquired pneumonia (92%); some were
enrolled in clinical trials for the antiviral drug remdesivir
(23%), interleukin-6ereceptor inhibitors (38%), or convalescent plasma therapy (15%).

RESULTS:
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FIGURE

Individual patient outcomes

A total of 13 pregnant or immediately postpartum women were admitted to the ICUs for COVID-19 and 8 required invasive mechanical ventilation.
Although 2 patients (15%) died, 11 (85%) were discharged alive.
COVID-19, coronavirus disease 2019; ICUs, intensive care units; SNF, skilled nursing facility.
Blitz. Maternal mortality among intensive care unit admissions for coronavirus disease 2019. Am J Obstet Gynecol 2020.

Of the 2 patients who died, 1 had a long, protracted course
in the ICU, which was complicated by fetal demise at a periviable gestational age; she developed multiple organ failure
and required renal replacement therapy, and after extensive
counseling in the setting of a poor maternal prognosis, the
family opted for no obstetrical intervention. She had a prepregnancy body mass index (BMI) greater than 40 kg/m2 and
OSA. The second patient who died had a rapid clinical
deterioration after delivery, which was complicated by severe
respiratory distress, multiple organ failure, and cardiopulmonary arrest.1 She had a prepregnancy BMI less than 30 kg/
m2 and no baseline comorbidities. Prone positioning to
improve oxygenation during mechanical ventilation was used
in the ﬁrst case but not in the second because of the patient’s
rapid clinical decline. These cases were critically reviewed by a
multidisciplinary team; it was determined that the standard of
care was met in both cases and that the outcomes were a
consequence of the disease process.
Of the 7 women (54%) who delivered during hospitalization for COVID-19, 5 (71%) were urgent or emergent cesarean deliveries in the setting of acute respiratory
decompensation, whereas 1 was an emergent cesarean delivery for cord prolapse during induction of labor for worsening respiratory symptoms, and 1 presented in labor and
delivered vaginally. There were 4 (57%) preterm births.
Maternal death occurred in 15% of patients
admitted to the ICUs for COVID-19 and in 25% of those who
required invasive mechanical ventilation. Delivery occurred in

CONCLUSION:
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half of the patients with COVID-19 who were admitted to the
ICUs and all patients who required invasive mechanical
ventilation. Hispanic women constituted the largest racial
or ethnic group in the study, which may reﬂect a
disproportionate burden of disease among minority groups.
Few studies have evaluated the characteristics and outcomes of critically ill pregnant women with COVID-19.
Interestingly, and in contrast with our ﬁndings, no cases of
maternal mortality were observed in the recent multicenter
cohort study by Pierce-Williams et al6 among pregnant
women hospitalized with severe or critical COVID-19. At
present, that study represents the largest report of such patients, but it is limited by the fact that half of the critically ill
patients (11/20) were still hospitalized at the completion of
data collection. In our study, approximately half of the
women admitted to the ICUs had no baseline comorbidities,
making it difﬁcult to identify those who were at highest risk
of respiratory failure and death. The patients were generally
older, multiparous, and racial or ethnic minorities, which
may reﬂect underlying disease prevalence (a product of
various factors, including household size and ability to social
distance) rather than intrinsic susceptibility to adverse outcomes. Larger studies are needed to determine which laboratory and imaging ﬁndings are most predictive of rapidly
progressive respiratory failure in pregnancy. In our study,
most patients were delivered in the setting of worsening
disease; it is not known how autotransfusion and other
physiological and immunologic changes immediately after
delivery affect maternal outcomes.
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The strengths of this study include consecutive patient
enrollment over a well-deﬁned time interval, explicit inclusion and exclusion criteria, utilization of data from a single
medical record system, and evaluation of clinically relevant
outcomes. In addition, no patients remained hospitalized at
study completion, allowing all in-hospital outcomes to be
fully evaluated, without omission, further reducing the risk of
bias. This study also has limitations. First, our sample size
remains small because of the rarity of ICU admissions of
pregnant women with COVID-19.5 During the study, ICU
bed availability was limited, and patients requiring considerable noninvasive respiratory support (eg, oxygen delivery by
using a nasal cannula or face mask) were often managed on
lower acuity units. Second, laboratory testing and radiologic
imaging were not uniform. Third, treatment algorithms
changed throughout the study period and were not identical
for all patients. Finally, the true prevalence of COVID-19
among pregnant women in these communities is unknown;
a SARS-CoV-2 testing strategy that only includes patients
admitted to the hospital, predominantly for delivery, does
no’t reﬂect this number. Universal testing for SARS-CoV-2
was implemented in the middle of the study period on our
obstetrical units. Thus, determining an accurate risk of ICU
admission or death among pregnant women infected with the
virus is not possible.
In summary, pregnant and postpartum women with
COVID-19 admitted to the ICUs are at risk for maternal
death, which may occur even in the absence of substantial
baseline comorbidities. Longitudinal population-based
cohort studies may offer more insights into mechanisms
determining which patients infected with the virus are at
highest risk.
In addition, in the Figure, patients 1 to 7 and 9 were
included in Richardson et al.4 Patient 7 was included in
Vallejo et al.1 Patients 1 to 4, 6, and 8 to 10 were included in
Blitz et al.5 Patients 12 to 13 were included in London et al7
and McLaren et al.8 Patients 3, 4, 6, 8, and 10 were included
in Gulersen et al.9
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SUPPLEMENTAL TABLE 1

Clinical characteristics of the patients
Characteristic

Patients (n[13)

Demographics
Maternal age, y

33.85.2

35

6 (46)

Race or ethnicity
Hispanic or Latino

5 (38)

Non-Hispanic white

4 (31)

Non-Hispanic black

1 (8)

Asian

3 (23)

Multiparous

9 (69)

Parity of 3 or more

6 (46)

BMI prepregnancy, kg/m2

30.26.7

30

5 (38)

Medical comorbidities
Hypertension

0 (0)

Diabetes

1 (8)

Asthma

2 (15)

Obstructive sleep apnea

1 (8)

Pregnancy complications
Gestational diabetes

1 (8)

Gestational hypertension or preeclampsia

3 (23)

COVID-19
Duration of illness before hospitalization, d

83

Duration of hospitalization before ICU admission, d

22

Previous hospital visit for respiratory symptoms

6 (46)

Gestational age at positive PCR result for SARS-CoV-2, wk

32.55.2

Gestational age at hospitalization, wk

33.35.3

On admission
Reported symptoms
Fever, subjective or measured

12 (92)

Cough

13 (100)

Dyspnea

10 (77)

Myalgia

6 (46)

Fatigue or malaise

3 (23)

Obstetrical complaints
Contractions

2 (15)

Decreased fetal movement

3 (23)

Blitz. Maternal mortality among intensive care unit admissions for coronavirus disease 2019. Am J Obstet Gynecol 2020.
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SUPPLEMENTAL TABLE 1

Clinical characteristics of the patients

(continued)

Characteristic

Patients (n[13)

Vital signs
Temperature, 100.4 F or 38 C

2 (15)

Heart rate, >100 beats per min

10 (77)

Respiratory rate, breaths per min
>30
Systolic blood pressure, mm Hg
Oxygen saturation, %
93
Data are presented as n (%) and meanstandard deviation unless otherwise specified.
BMI, body mass index; COVID-19, coronavirus disease 2019; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Blitz. Maternal mortality among intensive care unit admissions for coronavirus disease 2019. Am J Obstet Gynecol 2020.
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3 (23)
12218
925
9 (69)
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SUPPLEMENTAL TABLE 2

Laboratory results and imaging findings
Variable

Patients (n[13)

Reference rangesa

On admissionb
White blood cell count, 109/L
>10

7.9 (5.6e9.9)
3 (23)

3.8e10.5
—

Lymphocyte count, 109/L

0.8 (0.6e1.0)

1.0e3.3

Platelet count, 10 /mL

204 (166e246)

150e420

3

<150

2 (15)

Aspartate aminotransferase, U/L
>40
Alanine aminotransferase, U/L
>40

10e40

10 (77)

—

44 (21e67)

10e45

8 (62)

Venous lactate, mmol/L

1.0 (0.8e1.4)

>1.5

3 (23)

Serum creatinine, mg/dL

0.6 (0.5e0.7)

>1.1

2 (15)

Ferritin, ng/mL

112 (95e246)

D-dimer, ng/mL

613 (383e1169)

>1000

4 (31)

C-reactive protein, mg/dL
Procalcitonin, ng/mL
Creatine kinase, U/L

c

Troponin above test-specific upper limit of normal

—

81 (49e98)

—
0.7e2.0
—
0.5e1.30
—
15e400
0e229
—

20.1 (11.3e33.1)

0.0e0.40

0.8 (0.3e1.5)

0.02e0.10

33 (33e128)

25e200

3/10 (30)

—

11 (85)

—

0 (0)

—

Chest radiography
Bilateral infiltrates
Pleural effusion
During ICU stay
Highest serum creatinine, mg/dL
>2.5

0.7 (0.6e1.1)
2 (15)

Lowest platelet count, 10 /mL
3

<100
Highest aspartate aminotransferase, U/L
Highest alanine aminotransferase, U/L
Aminotransferase, >1000 U/L

152 (127e235)
3 (23)

—
—
—
—

103 (81e141)

—

97 (77e215)

—

3 (23)

—

5 (38)

—

Highest D-dimer, ng/mL
>3000
Data are presented as n (%), meanstandard deviation, and median (interquartile range).
ICU, intensive care unit.
a

Reference range established for nonpregnant patients; many of these laboratory tests change by trimester;
presentation; c Data available for 9 patients.

b

Defined as first test results available, typically within the first 24 hours of

Blitz. Maternal mortality among intensive care unit admissions for coronavirus disease 2019. Am J Obstet Gynecol 2020.
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SUPPLEMENTAL TABLE 3

Clinical management and outcomes
Variable

Patients (n[13)

ICU management
Invasive mechanical ventilation
Duration, d
Extubated

a

Prone positioning utilized

8 (62)
8 (2e19)
6/8 (75)
4/8 (50)

Extracorporeal membrane oxygenation

0 (0)

Vasopressors

7 (54)

Renal replacement therapy

1 (8)

Antiviral agent
Hydroxychloroquine
Remdesivir

11 (85)
3 (23)

Antibiotics for community-acquired pneumonia

12 (92)

Anticoagulation, prophylactic or therapeutic

13 (100)

Immunomodulatory agent

9 (69)

Corticosteroid (for maternal indication)

7 (54)

Interleukin-1 inhibitor

2 (15)

Interleukin-6 inhibitor

5 (38)

Convalescent plasma

2 (15)

Maternal outcomes
Length of stay, d
In hospital
In ICU
Delivery during hospitalization

13 (9e23)
8 (4e15)
7/13 (54)

Cesarean delivery for acute respiratory
decompensation

5/7 (71)

Cesarean delivery for obstetrical indication

1/7 (14)

Vaginal delivery

1/7 (14)

Died in hospital
Discharged from hospital
To home
To long-term care facility
Remained hospitalized at study completion

2 (15)
11 (85)
10 (77)
1 (8)
0 (0)

Neonatal outcomes
Gestational age at delivery, wk

36.92.0

Birthweight, g

2994569

Apgar scores
1 min7

3/8 (38)

5 min7

0/8 (0)

Blitz. Maternal mortality among intensive care unit admissions for coronavirus disease 2019. Am J Obstet Gynecol 2020.
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SUPPLEMENTAL TABLE 3

Clinical management and outcomes

(continued)

Variable
Positive PCR result for SARS-CoV-2 on first day of life

Patients (n[13)
b

0/7 (0)

Received antenatal corticosteroids

5 (50)

Gestational age at administration

29.14.2

Data are presented as n (%), meanstandard deviation, and median (interquartile range). Denominator is number of patients diagnosed as having COVID-19 at less than 37 weeks’ gestation.
COVID-19, coronavirus disease 2019; ICU, intensive care unit; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
a

One patient was extubated but remained ventilator dependent with a tracheostomy;

b

Results not available for 1 newborn.

Blitz. Maternal mortality among intensive care unit admissions for coronavirus disease 2019. Am J Obstet Gynecol 2020.
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